J&J Unit Denied Appeal Against Stelara Invalidation

By Ronan Barnard ( September 27, 2024, 11:57 PM BST) -- A London judge has refused to permit Janssen Biotech Inc. to challenge his July decision nixing the patent on its blockbuster Stelara drug, saying he had used "no magic" when using evidence derived from two patient cohorts in reaching his decision....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!